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Abstract
Objective The aims of the study were to analyse the surgical site infections (SSIs) in patients operated at an orthopaedic ward and
to describe the drug-resistance of the aetiology of those infections. Also, analyse the possibility of SSI control through micro-
biological surveillance. Additionally, we have studied the information inferred by aggregating cumulative antibiograms for the
SSIs of the studied orthopaedic unit.
Design Cross-sectional studies carried out in 2013–2015.
Setting and patients Orthopaedic and Trauma Surgery Unit in Sosnowiec, Poland; 5995 patients, 5239 operations.
Methods Retrospective laboratory-based data collection study of surgical site infections.
Results SSI incidence rate was 6.6%, in the implantations—hip prosthesis 5.8% and knee prosthesis 5.4%, about 6 times higher
compared with European HAI-Net. SSIs were usually caused by Gram-positive bacteria (56%). The prevalence of MDR microor-
ganisms was 22.6%, and mainly concerned the Gram-negative bacilli: 97.6% of Acinetobacter baumannii and 50.0% of Klebsiella
pneumoniae were multidrug-resistant. On the basis of what the Formula for Rational Empiric Antimicrobial Therapy analysis has
shown, the use of amikacin, imipenem and ciprofloxacin has been recommended as the most efficient in the empirical therapy of SSIs.
Conclusions The infection control was a significant problem at the studied orthopaedic unit, as evidenced by the SSI incidence
rate significantly higher than expected. We suggest implementing the infection control and prevention based on evidence-based
medicine, and a unit-based surveillance. A cumulative unit-based antibiogram reflects the drug-susceptibility pattern for the
strains from the infections acquired at the unit.
Keywords Orthopaedics . Laboratory-based surveillance . Surgical site infections . Multidrug-resistant microorganisms .
Cumulative antibiogram
Introduction
Surveillance is a systematic collection, analysis and interpre-
tation of health data. It is essential for the planning, implemen-
tation and evaluation of public health practice, especially
when hospital-acquired infections (HAIs) and antimicrobial
resistance are concerned [1].
The European Centre for Disease Control and Prevention
(ECDC) recommends an active, targeted surveillance of cer-
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The incidence of SSIs in surgical operations is estimated at
1.4–20%, depending on the procedure implemented: it
amounts to 1–3% for a primary arthroplasty, but is significant-
ly higher for a revision arthroplasty. The causative pathogens
depend on the type of surgery; the main etiological agents are
Gram-positive cocci, especially Staphylococcus spp.:
Staphylococcus aureus and coagulase-negative staphylococci,
in the endoarthroplasty, their share amounting to 70%, in or-
thopaedic trauma–related SSI about 35% [2–5].
Numerous patient- and procedure-related factors influence
the risk of SSI. Potential patient-related factors include malnu-
trition (serum albumin concentration), higher age, coexisting
infection and diabetes. External factors include the type and
duration of the operation, the quality of pre-operative skin
preparation, adequacy and timing of antimicrobial prophylax-
is, the insertion of foreign materials or implants, hair removal,
insufficient environmental hygiene or hand hygiene, and a bad
work organisation at the operating theatre. The risk is also
elevated by a prolonged pre-operative hospitalisation [6, 7].
Consequences of SSIs may be grave for both the patients
and the hospital. On average, SSIs extend the length of hos-
pital stay by two weeks, double the number of re-
hospitalizations and triple the cost of treatment—in compari-
son with the patients with no SSIs; in Poland, SSIs prolong the
hospitalisation period more than three times [7, 8].
The incidence of infections may be higher due to a signif-
icant rise in the number of implantations performed, and in the
age of the patients [9, 10].
The aims of the study were to analyse the epidemiology
and microbiology of the SSIs in patients operated at an ortho-
paedic ward and to describe the drug resistance of the
aetiology of those infections. Additionally, we have studied
the information inferred by aggregating cumulative
antibiograms for the SSIs of the studied unit.
Materials and methods
The laboratory-based study was conducted between 2013 and
2015 among 5995 patients of the Department and Clinic of
Orthopaedic and Trauma Surgery, St. Barbara Specialised
Regional Hospital No. 5, Sosnowiec. The hospital has the
largest emergency department in the region of Silesia in south-
ern Poland. The 38-bed department (including 6 beds at the
paediatric subunit) used for the research was a teaching unit
where students and residents are being trained. Emergencies
constituted 5% of all admissions to the unit. Five thousand
two hundred thirty-nine operations were performed in the
studied period, and the average length of hospitalisation was
8.8 days.
An independent microbiological laboratory working at the
hospital conducts some 2400 investigations of the clinical
materials for the unit per year. The infection control team
was composed of three epidemiological nurses, a doctor
specialised in contagious diseases and a microbiologist
specialised in diagnosis. Our experiences from the previous
years have already been partly discussed, but those discus-
sions concerned different types of infections and patient pop-
ulations [11, 12].
Three hundred forty-five SSI cases have been detected. The
aetiological factor could not be isolated in ten of them. Four
hundred two strains of the species considered as aetiological
factors of SSIs have been analysed.
In compliance with the International Classification of
Diseases, Ninth Revision, Clinical Modification (ICD-9-
CM), and with the methodology of the National Healthcare
Safety Network (NHSN), the operations performed have been
divided into: hip arthroplasties (HPROs), knee arthroplasties
(KPROs), other prostheses (OPROs) and other musculoskel-
etal surgery (OMSs). Cephazolin was applied in the pre-
operative antibiotic prophylaxis except for a closed reduction
of fracture with internal fixation (ICD-9, 79.1), where
cephtriaxone was used (as recommended by the Polish State
Consultant for Microbiology), and for simpler operations such
as an arthroscopy with no implant in place, where there was no
antibiotic prophylaxis.
The basic demographics of patients and the characteristics
of the SSIs have been collected. A retrospective analysis of the
SSIs, based on the reports of lab-based monitoring, has been
carried out in cooperation with the infection control team and
doctors working at the unit or at the ambulatory care, in com-
pliance with the ECDC definitions (https://ecdc.europa.eu/
sites/portal/files/documents/HAI-Net-SSI-protocol-v2.2.pdf).
The SSIs have been qualified as superficial/deep incisional or
organ/space. The follow-up period was 30 days for the super-
ficial SSIs and 90 days for deep or organ/space infections
following arthroplasties.
Microbiological tests (wound swabs, abscess or biopsy as-
pirates) were drawn when ordered by the attending physician.
Thirty-two percent of all materials had been collected through
biopsies. Only the non-repeating isolates have been included
in the study, excluding multiple strains coming from the same
SSI case. The strains have been identified using BD Phoenix
NID cards of the automated Phoenix 100 Becton Dickinson
Diagnostic System (Becton Dickinson, Warsaw, Poland) ac-
cording to the manufacturer’s instructions.
Antimicrobial susceptibility has been assessed according to
the current guidelines of the European Committee on
Antimicrobial Susceptibility Testing (EUCAST) (http://
www.eucast .org). The results of drug sensit ivi ty
examinations have been interpreted in compliance with the
EUCAST criteria. For Acinetobacter baumannii, ampicillin-
sulbactam susceptibility was assessed according to the guide-
lines of the Clinical Laboratory Standards Institute
(breakpoints R < 11, I = 12–15, S > 15). For the strains classi-
fied as multidrug-resistant (MDR), susceptibilities to colistin,
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tigecycline, ertapenem, imipenem, meropenem, amikacin,
gentamycin, tobramycin, trimethoprim-sulfamethoxazole,
ceftazidime and cefepime have also been examined.
Extended-spectrum beta-lactamase (ESBL) activity has
been detected by means of a modified double-disk synergy
test (DDST), using a combination of cefotaxime (5 μg), cef-
tazidime (10 μg), cefepime (30 μg) and aztreonam (30 μg)
disks, placed 20 mm apart around a disk containing
amoxicillin-clavulanate (20 μg/10 μg). Enhancement of the
inhibition zone toward the amoxicillin-clavulanate disks was
taken as a presumptive evidence of ESBL production.
The cumulative antibiogram reports have been prepared
using the Formula for Rational Empiric Antimicrobial
Therapy (FRAT) [13]. The latter had been calculated as the
microorganism prevalence multiplied by the drug sensitivity
rate—both figures based only on the microorganisms detected
and antibiotic groups applied in the studied SSI cases.
Statistical measures have been calculated for the sample:
the number of variants and the incidence for each variant, the
arithmetic mean and the standard deviation.
The results have been analysed by means of PQStat ver.
1.6.0.428, using the chi-squared test or Fisher’s exact test. The
Kendall rank correlation coefficient has been estimated for the
changes in antibiotic groups and in other scales throughout the
years. The p value was 0.05.
The use of the data has been approved by the Bioethical
Committee of Sosnowiec Medical College (No. PW/WSM/
36/17). All the data entered into the electronic database and
analysed in the study had been anonymised.
Results
Five thousand two hundred thirty-nine operations were per-
formed at the ward in the studied period. On average, patients
were aged 67 in the HPRO and KPRO, 49.6 in the OPRO and
49 in OMS. Male patients were operated on more
frequently—their cases constituted 51.7–58.1% of prosthesis
implantations and 70.2% of OMS.
An SSI has been detected 345 times, with an incidence rate
of 6.6%. Post-operative in-hospital SSI case fatality rate was
0.0%. No correlation between the sex of the patient and the
SSI incidence has been observed (chi2 = 0.86, df = 1, p =
0.353), but the age proved a significant risk factor (chi2 =
12.92, df = 5, p = 0.027): SSIs occurring most frequently for
the patients of 46–59 and 60–75 years of age (Table 1).
There has been a significant correlation between the type of
the surgery and the clinical form of the SSI (Fisher’s exact test,
p = 0.001): the latter was mostly superficial in arthroplasties
(although there were also many deep incisional SSIs in the hip
replacements), and deep incisional and organ/space in OMSs
(Table 2). There has also been a significant correlation be-
tween the type of the surgery and the time to detect the SSI
(Fisher’s exact test, p = 0.001). Thereby, the post-OMS SSIs
were mostly diagnosed even during the first hospitalisation,
whereas the post-arthroplasty SSIs were diagnosed most fre-
quently at the ambulatory care. Re-hospitalisation was needed
in 21.4% of KPROs and in 40.6% of HPROs (Table 2).
In the implantations—HPRO, KPRO, OPRO—the incidence
rate amounted to 5.8%, 5.4% and 5.3%, respectively, and was
not influenced by any of the risk factors we have been focusing
on, except the overall condition of the patient measured in the
ASA scale for the KPRO (chi2 = 4.45, df = 1, p = 0.0349)
(Table 3).
The incidence rate was the highest in other musculoskeletal
surgeries (OMSs), where it amounted to 7.7%. The rate was
higher in the cases in which the patient had been being
hospitalised for a long time prior to the surgery (t= − 3.64, df =
3187, p= 0.0003). The age of the patient (t= − 12.70, df = 3187,
p < 0.0001) and the wound contamination class (chi2 = 35.66,
df = 1, p< 0.0001) also influenced the incidence rate.
SSI aetiology
Most of the isolated microbes were the Gram-positive cocci
(56%, 225 strains, mostly coagulase-negative staphylococci
(CoNS) and Staphylococcus aureus). Among the Gram-
negative cocci, Acinetobacter baumannii was the most fre-
quent (Table 3). The yeast-like fungi (0.5%) had been isolated
from wound swabs.
MRSA prevalence was 26.2% (17 strains). The prevalence
of MDR microorganisms was 22.6%, mostly in the Gram-
negative bacilli: 97.6% of Acinetobacter baumannii and
50.0% of Klebsiella pneumoniae were multidrug-resistant.
The share of MDR strains did not change during the studied
period (tau = − 0.3, p = 0.60) (Table 4). On the basis of what
the FRAT analysis has shown, the use of amikacin (only in
combination therapy), imipenem and ciprofloxacin (in the ab-
sence of other therapeutic options) has been recommended as
the most efficient in the empirical therapy of SSIs (Table 4).
Discussion
The ultimate goal of surveillance is to reduce the risk of nos-
ocomial infections. The key means to achieve this are moni-
toring the infections (outcome measures) and overseeing the
elements of hospitalisation (process measures), including cer-
tain procedures and hand hygiene. The data, including the
information from a continuous prospective surveillance,
should flow between the staff smoothly and quickly if the
antibiotic policy of the hospital is to be effective.
However, rendering the surveillance satisfactorily effective
is a difficult task. It is even more difficult in the countries
where the hospital infection control is only now being intro-
duced, such as Poland [14]. A targeted active surveillance in
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Poland is run reluctantly and by few hospitals, and the inci-
dence is much higher than expected [15, 16]. Other countries
of the region have been facing similar problems, e.g. in 2000,
the SSI incidence rate for different types of surgeries in Russia
was 9.5% [17].
A rational infection control should include laboratory-
based monitoring. Microbiological diagnostic research is a
key element of identification and treatment of HAIs, SSIs
included [18]. The laboratory-based surveillance at the studied
hospital is run mostly by diagnostician’s microbiologist. The
epidemiological figures show that the cooperation between
them and the personnel of the unit—that is the detection and
identification of the SSIs, and acquiring the materials for clin-
ical research—was very good. However, the SSI incidence is
alarming high. This is probably due to insufficient compliance
of infection prevention and control practices—e.g. antibiotic
prophylaxis, surgical hand preparation, aseptic non-touch
technique and wound care—resulting from the lack of a con-
tinuous presence of an infection control professional (ICP) at
the ward and the lack of checking compliance of such proce-
dures. Thereby, a continuous laboratory-based monitoring has
not replaced the epidemiological surveillance successfully,
from the prevention point of view.
The highest incidence has been observed in OMSs. The
rate used to be much lower in the past: in 2003–2004, it
amounted to 1.2–1.3% in Poland [19, 20] and to 0.63% (pa-
tients with no risk factors) or 1.78% (patients with numerous
risk factors) in the USA [5]. What is more, the SSI rate for
arthroplasties at the studied ward is too high—several times
higher, while compared with the figures from other Polish
units, or from the USA [6, 8, 19–22]. This said, the analysis
of yearly (2011–2014) SSI incidence rates in EU countries has
shown a decreasing trend in the KPROs (p < 0.001).
It is difficult to identify a single cause of such an elevated
SSI incidence just on the basis of this laboratory-based study;
it is vital that a systematic and active surveillance, overseen by
an ICP, be introduced directly at the ward. It should not only
identify and register but also prevent the infections [23–26].
In Poland, SSI surveillance is rarely maintained once the
patient has left the hospital [27, 28]. At the studied hospital,
however, an effective laboratory-based monitoring has been
implemented in the ambulatory care. Many of the SSIs were
detected post-discharge, with no re-hospitalisation. A Finnish
study [29] has also observed an effective post-discharge sur-
veillance, but only some 2/3 of the SSIs detected by it were
confirmed in the microbiological analysis. This may be due to
the short post-surgery hospitalisation, which lasted 8 days in
the Finnish study [29] (or 12 days in China [30]), and was
longer in ours. We believe that the high SSI incidence is di-
rectly connected to an effective post-discharge surveillance,
rare in other European countries.
An elevated number of deep incisional infections had been
expected, as already described by other authors [8, 13]. A
Swiss research, however, points to a lower share of deep
incisional infections: 28.4% for hip replacements and 44.8%
for knee replacements, morbidity amounting to 1.4% and
0.9% respectively [31].
Most of the aetiological factors of the SSIs are Gram-
positive cocci, which are typical for orthopaedic patients
[32, 33], so is the fact that the coagulase-negative staphylo-
cocci (CoNS) constitute 20% of the factors [34]. On the other
hand, CoNS (possible skin contaminants) can be the evidence
of excessive sensitivity in detecting infections or finding the
infections. What is concerning is the frequent presence of
Acinetobacter baumannii, much higher than in the ECDC data
on orthopaedic infections, where it is estimated at 0.7% [34].
A. baumannii has also proved a major aetiological problem at
the ICU of the studied hospital, where it constituted 13.5% of
all pathogens from different clinical samples. 76.5% of strains
were extensively drug-resistant [35].
The SSIs caused by non-fermentative bacilli Acinetobacter
baumannii and Pseudomonas aeruginosa are particularly
Table 1 Characteristics of the
patients operated at the
Department and Clinic of
Orthopaedic and Trauma Surgery
in 2013–2015
Studied patients Incidence rate (%) OR (95%CI) p value
With SSI n = 345 Without SSI n = 4894
Age (year)
0–15 4 (1.2) 172 (3.5) 0.07 0.3 (0.12–0.87) p = 0.0272
16–29 59 (17.1) 784 (16.0) 1.13 1.1 (0.81–1.45)
30–45 76 (22.0) 1074 (21.9) 1.45 1.0 (0.77–1.31)
46–59 91 (26.4) 1185 (24.2) 1.74 1.1 (0.87–1.44)
60–75 100 (29.0) 1287 (26.3) 1.91 1.1 (0.89–1.46)
> 75 15 (4.3) 392 (8.00) 0.29 0.5 (0.31–0.88)
Gender
Female 139 (40.3) 2097 (42.8) 2.65 0.9 (0.72–1.12) p = 0.3531
Male 206 (59.7) 2797 (57.2) 3.93
OR (95%CI) odds ratio and 95% confidence interval, SSI surgical site infections
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difficult to treat, as these bacilli are often multidrug-resistant
[36–38].
This retrospective study had some limitations. Firstly, the
research involves only one centre. Secondly, in the period
studied, despite participation in the multiprofile programme,
the infection registration method was not validated; hence, its
sensitivity is not known in this particular case. Furthermore,
the other post-operative complications were not analysed,
Table 2 Characteristics of patients, operations and SSIs
Risk factors HPRO KPRO OPRO OMS
SSI SSI SSI SSI
No Yes No Yes No Yes No Yes
n = 552 n = 32 n = 2961 n = 14 n = 342 n = 18 n = 2961 n = 228
Duration of operation (min)
Mean 140 155 110 120 60 65 120 125
SD 42 43 36 36 16 16 38 38
p value 0.0503 0.3123 0.1971 0.0556
P75 (min) 160 130 94 135
Age (years)
Mean 67.0 69.1 66.8 69.0 49.8 46.7 47.9 62.0
SD 18 18 18 18 16 16 16 18
p value 0.5215 0.6564 0.4235 < 00001
The duration of the pre-hospitalisation (days)
Mean 6 6 6 6 4 4 3 4
SD 7 7 7 7 6 6 4 4
p value 1.0000 1.0000 1.0000 0.0003
Gender (%)
Male 55.3 53.1 58.1 57.1 51.5 55.6 70.6 64.5
Female 44.7 46.9 41.9 42.9 48.5 44.4 29.4 35.5
p value 0.8139 0.9413 0.7348 0.0520
OR (95%CI) 0.8 (0.57–1.19) 0.07 (0.04–0.11) 0.7 (0.5–1.2) 1.1 (0.9–1.3)
Cleanliness of the surgical site (%)
Clean, clean-contaminated 99.8 100.0 99.6 100.0 99.7 100.0 93.0 82.0
Contaminated, dirty 0.2 0.0 0.4 0.0 0.3 0.0 7.0 18.0
p value 0.8096 0.8155 0.8183 < 0.0001
OR (95%CI) 1.0 (0.61–1.66) 1.00 (0.48–2.11) 1.00 (0.51–1.96) 0.88 (0.72–1.1)
State of the patient in the ASA scale (%)
1 or 2 67.6 53.1 69.8 42.9 76.9 72.2 83.0 86.0
3 or 4 or 5 32.4 46.9 30.2 57.1 23.1 27.8 17.0 14.0
p value 0.0916 0.0349 0.6474 0.2503
OR (95%CI) 0.8 (0.9–3.8) 3.0 (1.1–8.9) 1.3 (0.4–3.7) 0.8 (0.5–1.2)
Incidence rate (%) 5.8 5.4 5.3 7.7
Clinical form of the SSI, n (%)
Superficial 16 (50.0) 12 (85.7) 15 (83.3) 97 (42.5)
Deep 14 (43.8) 2 (14.3) 3 (16.7) 125 (54.8)
Organ/space 2 (6.3) 0 (0.0) 0 (0.0) 6 (2.6)
Time of detection of SSI, n (%)
During hospital stay 7 (21.9) 4 (28.6) 4 (22.2) 139 (61.0)
Post-disleftge 12 (37.5) 7 (50.0) 14 (77.8) 49 (21.5)
Re-hospitalisation 13 (40.6) 3 (21.4) 0 (0.0) 40 (17.5)
ASA the American Society of Anesthesiologists physical status classification, HPRO hip endoarthroplasty, KPRO knee endoarthroplasty, OMS other
musculoskeletal,OPRO other prostheses,OR (95%CI) odds ratio and 95% confidence interval, P75 75th percentile of duration of operation, SD standard
deviation, SSI surgical site infections
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which can extend the hospital stay, delay rehabilitation and
impact patient satisfaction like non-surgical infections, non-
union and delayed union, or post-operative nausea and
vomiting [39–42]. Also, demographic information for the
study population was limited; thus, data on the characteristics
of the patients (for example, peri-operative bacteriuria, bacte-
rial contamination rate of electrocautery tips, smoking) were
unavailable, as well as differences in the type of care received
by the patients, for example, dressing type [43–45].
To conclude, the study has validated the usefulness of a
laboratory-based monitoring of SSIs. On the other hand, it
has revealed that the infection control was a significant
problem at the studied orthopaedic unit: the SSI rates were
significantly higher than expected. This phenomenon may
be due to inadequate local infection control. We suggest
implementing the infection control and prevention based on
evidence-based medicine [23]. An active unit-based
surveillance—not only monitoring—is even more important.
Such an active SSI surveillance should be adopted by other
hospitals in Poland.
A cumulative unit-based antibiogram reflects the drug-
susceptibility pattern for the strains from the infections ac-
quired at the unit. It may be useful in choosing the empirical
antibacterial therapy.
Table 3 Most frequently isolated
aetiological factors of SSIs at the
Department and Clinic of
Orthopaedic and Trauma Surgery
in 2013–2015
Pathogen n (%) Ranking MDR*, n (%) Trend of occurrence
Gram-positive 225 (56.0) n/a
Coagulase-negative staphylococci 81 (20.1) 1
Staphylococcus aureus 65 (16.1) 2 17 (26.2)** Tau = 0.3; p = 0.60
Enterococcus faecalis 49 (12.2) 3 n/a
Enterococcus faecium 10 (2.5) 9
Others 20 (5.0) 8
Gram-negative 175 (43.5)
Acinetobacter baumannii 41 (10.2) 4 40 (97.6) Tau = − 0.8; p = 0.20
Escherichia coli 30 (7.5) 5 4 (16.7) Tau = 0.8; p = 0.20
Klebsiella pneumoniae 22 (5.5) 6 11 (50.0) Tau = − 1.0; p = 0.12
Enterobacter cloacae 21 (5.2) 7 n/a
Proteus mirabilis 20 (5.0) 8 7 (35.0) Tau = 1.0; p = 0.12
Pseudomonas aeruginosa 20 (5.0) 8 4 (20.0) Tau = 1.0; p = 0.12
Others 21 (5.2) 7 n/a
Candida spp. 2 (0.5)
Total 402 (100) 91 (22.6) Tau = − 0.3; p = 0.60
*Other MDR 8 (3.8%)
**Only MRSA
MDR multidrug-resistant, including extended-spectrum beta-lactamases (ESBL) and methicillin-resistant
Staphylococcus aureus (MRSA), n/a not available
Table 4 The cumulative
antibiogram report, prepared in
compliance with the Formula for
Rational Empiric Antimicrobial
Therapy (FRAT)
Pathogen %I Amikacin Ceftazidime Ciprofloxacin Imipenem
%S IF %S IF %S IF %S IF
Coagulase-negative staphylococcus 20.1 6 1.2 n/a n/a 24 4.8 n/a n/a
Staphylococcus aureus 16.2 50 8.1 n/a n/a 53 7.0 n/a n/a
Acinetobacter baumannii 10.2 3 0.3 0 0 4 0.4 17 1.7
Escherichia coli 6.0 82 4.9 71 4.3 65 4.0 100 6
Klebsiella pneumoniae 5.5 60 3.9 38 2.1 46 2.5 100 5.5
Enterobacter cloacae 5.2 95 4.9 71 3.7 87 4.5 100 5.2
Proteus mirabilis 5.0 67 3.4 68 3.4 50 2.5 29 1.5
Pseudomonas aeruginosa 5.0 100 5.0 89 4.5 68 3.4 80 4
Percentage of overall activity 43.3 24.6 29.8 32.7
n/a not available; %I percentage frequency of isolation, %S percentage sensitivity of pathogen to antibiotic, IF
antimicrobial impact factor: the likelihood that a pathogen would be sensitive to an antimicrobial drug,
(%I ×%S) 100
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